Back to search

Article

Use of Human Lung Tissue Models for Screening of Drugs Against SARS-CoV-2 Infection

2022-09-20

Abstract excerpt

The repurposing of licenced drugs for use against COVID-19 is one of the most rapid ways to develop new and alternative therapeutic options to manage the ongoing pandemic. Given the approximately 8,000 licenced compounds available from Compounds Australia that can be screened, this paper demonstrates the utility of commercially-available ex vivo/3D airway and alveolar tissue models. These models are a closer repre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a745d47d-de8d-531e-aae3-5b34b264ed63
DOI
10.20944/preprints202209.0288.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Use of Human Lung Tissue Models for Screening of Drugs Against SARS-CoV-2 InfectionDOI 10.20944/preprints202209.0288.v1
Select a neighboring publication to make it the new centre.